03:44 AM EST, 11/06/2025 (MT Newswires) -- Astrazeneca ( AZN ) reported Q3 core earnings Thursday of $2.38 per share, up 14% from a year earlier.

Analysts surveyed by FactSet expected $2.29.

Revenue for the quarter ended Sept. 30 was $15.19 billion, up 12% from a year earlier.

Analysts polled by FactSet expected $15.42 billion.

For 2025, the biopharmaceutical company reiterated its expectation of core EPS high single-digit percentage growth and low double-digit percentage revenue growth at constant exchange rates.